Meeting | Mixed
Event Title
FDA Expert Panel on Talc
May 20, 2025
Event Title
FDA Expert Panel on Talc
- Date:
- May 20, 2025
- Time:
- 10:00 a.m. - 12:00 p.m. ET
Independent Expert Panel to Evaluate Safety and Necessity of Talc in Food, Drug, and Cosmetic Products
Background:
Talc, a naturally occurring mineral used in a variety of consumer products, has come under increased scrutiny due to concerns about potential health effects, especially when contaminated with asbestos or consumed over prolonged periods. The panel reviewed data related to talc exposure and evaluate its continued use within the context of public health needs and available alternatives.
Panelists:
- Martin A. Makary, M.D., M.P.H., FDA Commissioner
- Sara Brenner M.D., M.P.H., FDA Principal Deputy Commissioner
- George Tidmarsh M.D., Ph.D., Adjunct Professor, Pediatrics - Neonatology, Stanford
- John Joseph Godleski, M.D., Professor of Pathology, Emeritus (Brigham and Women's)
- Sandra McDonald M.D., Professor of Pathology, Emeritus (Brigham and Women's)
- Daniel Cramer M.D., Sc.D., Professor of Obstetrics, Gynecology and Reproductive Biology, Part-Time (Brigham and Women's)
- Joellen Schildkraut Ph.D., M.P.H., Professor, Department of Epidemiology, Emory University
- Malcolm Sim, Ph.D., M.B.B.S., M.Sc., Emeritus Professor, Planetary Health, Monash University (Emeritus) Australia
- Steven Pfeiffer, Ph.D., M.B.A., Senior Vice President of Technical Operations, Mirador Therapeutics
- Nicolas Wentzensen M.D., Ph.D., M.S., Clinical Genetics Branch, National Cancer Institute,
- Nicole C. Kleinstreuer, Ph.D., Acting NIH Deputy Director for Program Coordination, Planning, and Strategic Initiatives.
Press Release: FDA to Host Inaugural, Independent, Scientific Expert Panel Open to Public
Webcast Recording: https://www.youtube.com/live/MS-T1KicGOc
Media Inquiries: HHS Press Office